In a murine psoriasis model generated by intradermal IL-23 injection, treatment with an anti–CCL20 antibody significantly reduced the recruitment of CCR6+ cells and attenuated IL-23–induced psoriasiform dermatitis [33]. Here, CCL20 is linked to psoriasis.